New drug injection aims to help shed pounds in early safety trial
NCT ID NCT07476118
Summary
This is an early-stage study to test the safety and effects of a new injectable drug called brenipatide in healthy adults who are overweight or have obesity. Researchers will give different doses to about 150 participants to see how the body handles the drug and if it helps reduce body weight. The main goal is to find a safe and effective dose for future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fortrea Clinical Research Unit
Dallas, Texas, 75247, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit - Daytona Beach
Daytona Beach, Florida, 32117-5116, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit Inc. - Madison
Madison, Wisconsin, 53704, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.